TickerFacts.

Bioharvest Sciences Inc. (BHST): Cost of Revenue

Annual figures by period end, from SEC filings.

$14.03M
Year ended 2025-12-31
2023-12-31: $7.04M2024-12-31: $11.25M2025-12-31: $14.03M$14.03M
2023-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$14.03M+24.8%2026-03-31, From 2025-01-01
2024-12-31$11.25M+59.8%2026-03-31, From 2024-01-01
2023-12-31$7.04Mn/a2025-03-31, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Bioharvest Sciences Inc. (BHST)2025-12-31$14.03M+24.8%
Verrica Pharmaceuticals Inc. (VRCA)2024-12-31$2.60M+420.0%
Earth Science Tech, Inc. (ETST)2026-03-31$10.21M+15.8%
Sunshine Biopharma Inc. (SBFM)2025-12-31$24.05M-0.6%
Lftd Partners Inc. (LIFD)2025-12-31$24.30M-1.1%
Zomedica Corp. (ZOMDF)2025-12-31$10.35M+26.3%
BGM Group Ltd. (BGM)2025-09-30$31.61M+50.6%
Integrated Biopharma Inc (INBP)2026-06-30$43.07M-11.7%
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$6.67M+1.2%

Compare BHST, VRCA, ETST, SBFM side by side · Screen every company in Pharmaceutical Preparations ↗